[go: up one dir, main page]

WO2000011965A3 - Compositions pouvant etre ingerees, comprenant des agents antibacteriens - Google Patents

Compositions pouvant etre ingerees, comprenant des agents antibacteriens Download PDF

Info

Publication number
WO2000011965A3
WO2000011965A3 PCT/GB1999/002845 GB9902845W WO0011965A3 WO 2000011965 A3 WO2000011965 A3 WO 2000011965A3 GB 9902845 W GB9902845 W GB 9902845W WO 0011965 A3 WO0011965 A3 WO 0011965A3
Authority
WO
WIPO (PCT)
Prior art keywords
formulation
antibacterial agents
ingestible compositions
human
gut
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB1999/002845
Other languages
English (en)
Other versions
WO2000011965A2 (fr
Inventor
David Russell Blake
Clifford Robert Stevens
Robert Eisenthal
Roger Harrison
Timothy Mark Millar
Rachel Edwards
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Bath
Original Assignee
University of Bath
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9818913.7A external-priority patent/GB9818913D0/en
Priority claimed from GBGB9827243.8A external-priority patent/GB9827243D0/en
Application filed by University of Bath filed Critical University of Bath
Priority to EP99941769A priority Critical patent/EP1143808B1/fr
Priority to AU55264/99A priority patent/AU5526499A/en
Priority to DE69941459T priority patent/DE69941459D1/de
Priority to AT99941769T priority patent/ATE443452T1/de
Priority to GB0106182A priority patent/GB2370486A/en
Publication of WO2000011965A2 publication Critical patent/WO2000011965A2/fr
Anticipated expiration legal-status Critical
Publication of WO2000011965A3 publication Critical patent/WO2000011965A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/1203—Addition of, or treatment with, enzymes or microorganisms other than lactobacteriaceae
    • A23C9/1213—Oxidation or reduction enzymes, e.g. peroxidase, catalase, dehydrogenase
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/189—Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/06—Enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y117/00—Oxidoreductases acting on CH or CH2 groups (1.17)
    • C12Y117/03—Oxidoreductases acting on CH or CH2 groups (1.17) with oxygen as acceptor (1.17.3)
    • C12Y117/03002—Xanthine oxidase (1.17.3.2)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Husbandry (AREA)
  • Wood Science & Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Fodder In General (AREA)

Abstract

L'invention concerne une formulation prévue pour être utilisée comme agent bactéricide dans le système digestif de l'homme ou de l'animal. Cette formulation comprend de l'oxydoréductase de xanthine. Cette formulation peut se présenter particulièrement sous forme d'une formulation de lait artificiel ou d'une formulation pour alimentation par voie entérale, destinée à être administrée tant à l'homme qu'à l'animal. Cette formulation peut jouer le rôle d'un «antibiotique naturel» pour empêcher ou réduire l'infection bactérienne dans les intestins, en particulier, chez le nouveau-né.
PCT/GB1999/002845 1998-08-28 1999-08-27 Compositions pouvant etre ingerees, comprenant des agents antibacteriens Ceased WO2000011965A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP99941769A EP1143808B1 (fr) 1998-08-28 1999-08-27 Procede de fabrication de compositions pouvant etre ingerees, comprenant des agents antibacteriens
AU55264/99A AU5526499A (en) 1998-08-28 1999-08-27 Ingestible compositions comprising antibacterial agents
DE69941459T DE69941459D1 (de) 1998-08-28 1999-08-27 Verfahren zur herstellung von essbaren zusammenstellungen mit antibakteriellen wirkstoffen
AT99941769T ATE443452T1 (de) 1998-08-28 1999-08-27 Verfahren zur herstellung von essbaren zusammenstellungen mit antibakteriellen wirkstoffen
GB0106182A GB2370486A (en) 1998-08-28 1999-08-27 Ingestible compositions comprising antibacterial agents

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9818913.7A GB9818913D0 (en) 1998-08-28 1998-08-28 Compositions comprising xanthine oxidoreductase
GB9818913.7 1998-08-28
GB9827243.8 1998-12-10
GBGB9827243.8A GB9827243D0 (en) 1998-12-10 1998-12-10 Compositions comprising xanthine oxidoreductase

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US09763791 A-371-Of-International 2001-04-25
US10/732,679 Continuation US20040120938A1 (en) 1998-08-28 2003-12-10 Ingestible compositions comprising antibacterial agents

Publications (2)

Publication Number Publication Date
WO2000011965A2 WO2000011965A2 (fr) 2000-03-09
WO2000011965A3 true WO2000011965A3 (fr) 2001-08-23

Family

ID=26314289

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1999/002845 Ceased WO2000011965A2 (fr) 1998-08-28 1999-08-27 Compositions pouvant etre ingerees, comprenant des agents antibacteriens

Country Status (6)

Country Link
EP (1) EP1143808B1 (fr)
AT (1) ATE443452T1 (fr)
AU (1) AU5526499A (fr)
DE (1) DE69941459D1 (fr)
GB (1) GB2370486A (fr)
WO (1) WO2000011965A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7335383B2 (en) 2001-01-16 2008-02-26 The Regents Of The University Of Michigan Generation of nitric oxide in vivo from nitrite, nitrate or nitrosothiols endogenous in blood
US7128904B2 (en) 2001-01-16 2006-10-31 The Regents Of The University Of Michigan Material containing metal ion ligand complex producing nitric oxide in contact with blood
ES2312547T3 (es) * 2001-01-16 2009-03-01 The Regents Of The University Of Michigan Generacion biocatalitica y biomimetica in situ de oxido nitrico en interfases sustrato/sangre.
ATE314808T1 (de) * 2002-08-12 2006-02-15 Bayer Cropscience Sa Neues 2-pyridylethylbenzamid-derivat

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0477143A2 (fr) * 1990-08-30 1992-03-25 Idi Farmaceutici S.P.A. Composition pharmaceutique ayant en effect cicatrisant
EP0518445A1 (fr) * 1991-06-11 1992-12-16 Gist-Brocades N.V. Activité antimicrobienne prolongée par la libération retardée du péroxyde d'hydrogène
WO1993023080A1 (fr) * 1992-05-13 1993-11-25 The Beth Israel Hospital Association Cytotoxicite d'especes activees ciblees
US5310541A (en) * 1992-08-27 1994-05-10 Montgomery Robert E Antimicrobial rawhide animal chew containing an oxidoreductase and oxidoreductase substrate
US5645834A (en) * 1992-08-28 1997-07-08 Immuno-Dynamics, Inc. Method and product for treating failure of passive transfer and improving milk production in bovine species

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8701839L (sv) * 1987-05-05 1988-11-06 Ewos Ab Livs- och fodermedel

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0477143A2 (fr) * 1990-08-30 1992-03-25 Idi Farmaceutici S.P.A. Composition pharmaceutique ayant en effect cicatrisant
EP0518445A1 (fr) * 1991-06-11 1992-12-16 Gist-Brocades N.V. Activité antimicrobienne prolongée par la libération retardée du péroxyde d'hydrogène
WO1993023080A1 (fr) * 1992-05-13 1993-11-25 The Beth Israel Hospital Association Cytotoxicite d'especes activees ciblees
US5310541A (en) * 1992-08-27 1994-05-10 Montgomery Robert E Antimicrobial rawhide animal chew containing an oxidoreductase and oxidoreductase substrate
US5645834A (en) * 1992-08-28 1997-07-08 Immuno-Dynamics, Inc. Method and product for treating failure of passive transfer and improving milk production in bovine species

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MILLAR T.M. ET AL: "Xanthine oxidase catalyses the reduction of nitrates and nitrite to nitric oxide under hypoxic conditions", FEBS LETTERS, May 1998 (1998-05-01), pages 225 - 228, XP002133526 *

Also Published As

Publication number Publication date
DE69941459D1 (de) 2009-11-05
GB0106182D0 (en) 2001-05-02
AU5526499A (en) 2000-03-21
ATE443452T1 (de) 2009-10-15
GB2370486A (en) 2002-07-03
WO2000011965A2 (fr) 2000-03-09
EP1143808A2 (fr) 2001-10-17
EP1143808B1 (fr) 2009-09-23

Similar Documents

Publication Publication Date Title
BR0013010A (pt) Formulação de cloreto de sódio de moxifloxacina
CA2415068A1 (fr) Renforcement global de l'organisme
BG103945A (en) Derivatives of 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a
WO2001092288A3 (fr) Composes de cobalamine utilises comme agents antibiotiques et comme agents d'imagerie
PT806941E (pt) Composicoes anti-bacterianas liposomicas de rigidez baixa
JP2005511642A5 (fr)
WO2001041785A3 (fr) Traitement enzymatique des infections
GB0031312D0 (en) Macrolides
US6017912A (en) Topical fluoroquinolone antibiotics in an alcohol and acetone vehicle
IL136062A0 (en) Oxazolidinone derivatives and pharmaceutical compositions
TW264386B (fr)
EP1228758A4 (fr) Agents de prevention ou de traitement de maladies inflammatoires de l'intestin
GEP20043202B (en) Resorcinol Derivatives
CA2386685A1 (fr) Utilisation de derives de pleuromutiline pour le traitement transdermique de maladies bacteriennes
PH27446A (en) Compound with gastric acid inhibitory effect
WO2000011965A3 (fr) Compositions pouvant etre ingerees, comprenant des agents antibacteriens
GEP20032970B (en) Pharmaceutical Compositions of Tizoxanide and Nitazoxanide
CA2425319A1 (fr) Traitement et prophylaxie de maladies et d'infections des porcs et de la volaille
AU2615795A (en) Compounds and compositions for administration via oral inhalation or insufflation
WO2004039822A3 (fr) Composes
HU0102987D0 (en) Pharmaceutical composition for treating parkinson's disease comprising astrocyte function-improving agent as active ingredient
BR9807444A (pt) Produto antimicrobial
AU7237698A (en) Medicinal compositions against helicobacter pylori
GR3026590T3 (en) Antibiotics ge 37468 a, b and c.
NZ503027A (en) Use of rifamycin derivative for treating mastitis in a domestic animal

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref country code: GB

Ref document number: 200106182

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1999941769

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2001/02372

Country of ref document: ZA

Ref document number: 200102372

Country of ref document: ZA

WWE Wipo information: entry into national phase

Ref document number: 09763791

Country of ref document: US

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1999941769

Country of ref document: EP